Delivery Order SPE2DR25D1100-SPE2DR26FCM4A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a ceiling value of $1,089.41. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement process. The order is set to reach completion by November 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count), with a ceiling value of $4,436.68 and an ultimate completion date of October 31, 2025. This non-set-aside, firm fixed-price delivery order represents a small-value pharmaceutical procurement under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $13,758.08 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count supply) on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award...
- The Defense Logistics Agency awarded a $31,540.49 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 13, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $11,097.32 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count supply). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 23, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $22,444.29 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of September 19, 2025. The product will be performed and distributed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $3,961.34 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price delivery order with no set-aside designation, issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a ceiling value of approximately $30.2K. This is a firm fixed-price delivery order issued under a non-competitive set-aside arrangement, reflecting AmerisourceBergen's established status as a critical pharmaceutical vendor within the federal medical supply chain. The order is set to be completed by July 1, 2025, and...
- The Defense Logistics Agency awarded a delivery order valued at $5,535.71 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $3,705.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This non-competitive delivery order, with an ultimate completion date of October 20, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCM4ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,734.12 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count). This competitively awarded, firm fixed-price contract carries an ultimate completion date of November 5, 2025, and represents a small-value pharmaceutical procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order was issued without any set-aside designation, reflecting open competition among qualified suppliers. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Trelegy Ellipta is a combination respiratory therapy medication used in pulmonary disease management, and this procurement supports the ongoing pharmaceutical supply needs of the Defense Health Agency and other federal healthcare systems. As a major pharmaceutical distributor serving federal medical procurement requirements, AmerisourceBergen Drug Corp leverages its extensive distribution network and product portfolio to fulfill critical medication needs across the defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 11/4/25 |